Suppr超能文献

合生元补充剂在预防肥胖及肥胖相关疾病中的作用

Synbiotic Supplements in the Prevention of Obesity and Obesity-Related Diseases.

作者信息

Hijová Emília

机构信息

Center of Clinical and Preclinical Research (MEDIPARK), Department of Experimental Medicine, Faculty of Medicine, Pavol Jozef Šafárik University, 040 11 Košice, Slovakia.

出版信息

Metabolites. 2022 Mar 31;12(4):313. doi: 10.3390/metabo12040313.

Abstract

Obesity and being overweight have reached incredible proportions worldwide and are one of the most common human health problems. The causes of obesity are multifactorial, including a complex interplay among genes, metabolism, diet, physical activity, and the environment. The intestinal microbiota has the ability to affect the host physiology for both benefit and damage, either directly or through microbial metabolites. The aim of this review is to discuss the mechanisms by which the intestinal microbiota could act as a key modifier of obesity and related metabolic abnormalities. The synbiotic components provide an optimal target for modulation of the intestinal microbiota and help reshape the metabolic profile in obese people. The development of novel functional foods containing synbiotic ingredients may present a support in the prevention of obesity as one of the risk factors for chronic diseases. Knowledge of the synbiotic mechanisms of action and the use of new functional foods supplemented with probiotics and prebiotics will facilitate the clinical application and development of individual health care strategies.

摘要

肥胖和超重问题在全球范围内已达到惊人的程度,是最常见的人类健康问题之一。肥胖的成因是多方面的,包括基因、新陈代谢、饮食、身体活动和环境之间的复杂相互作用。肠道微生物群有能力直接或通过微生物代谢产物对宿主生理产生有益或有害的影响。本综述的目的是讨论肠道微生物群作为肥胖及相关代谢异常的关键调节因子的作用机制。合生元成分是调节肠道微生物群的最佳靶点,有助于重塑肥胖人群的代谢状况。开发含有合生元成分的新型功能性食品可能有助于预防肥胖这一慢性疾病风险因素。了解合生元的作用机制以及使用添加益生菌和益生元的新型功能性食品将促进临床应用和个体医疗保健策略的发展。

相似文献

1
Synbiotic Supplements in the Prevention of Obesity and Obesity-Related Diseases.
Metabolites. 2022 Mar 31;12(4):313. doi: 10.3390/metabo12040313.
4
Probiotics and prebiotics, targeting obesity with functional foods.
Bratisl Lek Listy. 2021;122(9):647-652. doi: 10.4149/BLL_2021_104.
10
Efficacy of dietary supplements targeting gut microbiota in the prevention and treatment of gestational diabetes mellitus.
Front Microbiol. 2022 Jul 14;13:927883. doi: 10.3389/fmicb.2022.927883. eCollection 2022.

引用本文的文献

1
The Significance of Probiotics in Aquaculture: A Review of Research Trend and Latest Scientific Findings.
Antibiotics (Basel). 2025 Feb 27;14(3):242. doi: 10.3390/antibiotics14030242.
2
Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration.
Front Endocrinol (Lausanne). 2025 Jan 17;15:1456948. doi: 10.3389/fendo.2024.1456948. eCollection 2024.
3
Effect of synbiotic supplementation on obesity and gut microbiota in obese adults: a double-blind randomized controlled trial.
Front Nutr. 2024 Nov 27;11:1510318. doi: 10.3389/fnut.2024.1510318. eCollection 2024.
6
Probiotic for Pancreatic β-Cell Function in Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
Diabetes Ther. 2023 Nov;14(11):1915-1931. doi: 10.1007/s13300-023-01474-6. Epub 2023 Sep 15.
7
Weight Loss Supplements.
Molecules. 2023 Jul 12;28(14):5357. doi: 10.3390/molecules28145357.
10
The Firmicutes/Bacteroidetes Ratio as a Risk Factor of Breast Cancer.
J Clin Med. 2023 Mar 13;12(6):2216. doi: 10.3390/jcm12062216.

本文引用的文献

1
Intestinal Barrier Function and Immune Homeostasis Are Missing Links in Obesity and Type 2 Diabetes Development.
Front Endocrinol (Lausanne). 2022 Jan 25;12:833544. doi: 10.3389/fendo.2021.833544. eCollection 2021.
2
Gut microbiota and vitamin status in persons with obesity: A key interplay.
Obes Rev. 2022 Feb;23(2):e13377. doi: 10.1111/obr.13377. Epub 2021 Nov 12.
3
Oscillospira - a candidate for the next-generation probiotics.
Gut Microbes. 2021 Jan-Dec;13(1):1987783. doi: 10.1080/19490976.2021.1987783.
4
Effects of synbiotic supplement on body weight and fasting blood glucose levels in obesity: A randomized placebo-controlled trial.
Ann Med Surg (Lond). 2021 Jul 9;68:102548. doi: 10.1016/j.amsu.2021.102548. eCollection 2021 Aug.
5
A review on gut microbiota: a central factor in the pathophysiology of obesity.
Lipids Health Dis. 2021 Jul 7;20(1):65. doi: 10.1186/s12944-021-01491-z.
7
Probiotics, Pre-biotics and Synbiotics in the Treatment of Pre-diabetes: A Systematic Review of Randomized Controlled Trials.
Front Public Health. 2021 Mar 26;9:645035. doi: 10.3389/fpubh.2021.645035. eCollection 2021.
8
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases.
Molecules. 2021 Jan 28;26(3):682. doi: 10.3390/molecules26030682.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验